Validity of the Gender Dysphoria diagnosis and incidence trends in Sweden: a nationwide register study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 08 2021
Historique:
received: 18 09 2020
accepted: 23 07 2021
entrez: 10 8 2021
pubmed: 11 8 2021
medline: 12 11 2021
Statut: epublish

Résumé

The aim of this study was to examine the validity of the Gender Dysphoria (GD) diagnoses in the Swedish National Patient Register (NPR), to discuss different register-based definitions of GD and to investigate incidence trends. We collected data on all individuals with registered GD diagnoses between 2001 and 2016 as well as data on the coverage in the NPR. We regarded gender confirming medical intervention (GCMI) as one proxy for a clinically valid diagnosis and calculated the positive predictive value (PPV) for receiving GCMI for increasing number of registered GD diagnoses. We assessed crude and coverage-adjusted time trends of GD during 2004-2015 with a Poisson regression, using assigned sex and age as interaction terms. The PPV for receiving GCMI was 68% for ≥ 1 and 79% for ≥ 4 GD-diagnoses. The incidence of GD was on average 35% higher with the definition of ≥ 1 compared to the definition of ≥ 4 diagnoses. The incidence of GD, defined as ≥ 4 diagnoses increased significantly during the study period and mostly in the age categories 10-17 and 18-30 years, even after adjusting for register coverage. We concluded that the validity of a single ICD code denoting clinical GD in the Swedish NPR can be questioned. For future research, we propose to carefully weight the advantages and disadvantages of different register-based definitions according to the individual study's needs, the time periods involved and the age-groups under study.

Identifiants

pubmed: 34373498
doi: 10.1038/s41598-021-95421-9
pii: 10.1038/s41598-021-95421-9
pmc: PMC8352918
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

16168

Informations de copyright

© 2021. The Author(s).

Références

Arch Sex Behav. 2018 Jul;47(5):1301-1304
pubmed: 29696550
BJPsych Bull. 2018 Oct;42(5):206-210
pubmed: 29893661
Arch Sex Behav. 2014 Nov;43(8):1535-45
pubmed: 24872188
PLoS One. 2018 Oct 5;13(10):e0204606
pubmed: 30289896
Best Pract Res Clin Endocrinol Metab. 2015 Jun;29(3):485-95
pubmed: 26051304
Sex Health. 2017 Oct;14(5):404-411
pubmed: 28838353
J Sex Marital Ther. 2018;44(7):713-715
pubmed: 29412073
Eur Psychiatry. 2015 Sep;30(6):807-15
pubmed: 26021270
Arch Sex Behav. 2014 Feb;43(2):377-85
pubmed: 23857516
Int Rev Psychiatry. 2016;28(1):44-57
pubmed: 26835611
Adolesc Health Med Ther. 2018 Mar 02;9:31-41
pubmed: 29535563
Child Adolesc Psychiatry Ment Health. 2015 Apr 09;9:9
pubmed: 25873995
Arch Sex Behav. 2010 Apr;39(2):499-513
pubmed: 19838784
Arch Sex Behav. 2020 Oct;49(7):2661-2672
pubmed: 31713095
Arch Sex Behav. 2010 Apr;39(2):477-98
pubmed: 19842027
Lakartidningen. 2019 Oct 11;116:
pubmed: 31613373
PLoS One. 2018 Aug 16;13(8):e0202330
pubmed: 30114286
J Sex Med. 2015 Mar;12(3):756-63
pubmed: 25612159
Arch Sex Behav. 2013 Jul;42(5):901-14
pubmed: 23868018
J Sex Med. 2018 Apr;15(4):582-590
pubmed: 29463477
J Sex Med. 2018 Oct;15(10):1381-1383
pubmed: 30195563
World Psychiatry. 2016 Oct;15(3):205-221
pubmed: 27717275
Eur Child Adolesc Psychiatry. 2020 Jun;29(6):803-811
pubmed: 31473831
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213
Basic Clin Pharmacol Toxicol. 2016 Nov;119(5):464-469
pubmed: 27112967
Scand J Soc Med. 1990 Jun;18(2):143-8
pubmed: 2367825
Hormones (Athens). 2020 Sep;19(3):267-276
pubmed: 32020566
LGBT Health. 2016 Jun;3(3):181-5
pubmed: 27135657
Lancet. 2016 Jul 23;388(10042):390-400
pubmed: 27323925

Auteurs

Malin Indremo (M)

Department of Neuroscience, Psychiatry, Uppsala University, Uppsala, Sweden. malin.indremo@neuro.uu.se.

Richard White (R)

Norwegian Institute of Public Health, Oslo, Norway.

Thomas Frisell (T)

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.

Sven Cnattingius (S)

Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.

Alkistis Skalkidou (A)

Institute of Women's and Children's Health, Obstetrics and Gynecology, Uppsala University, Uppsala, Sweden.

Johan Isaksson (J)

Department of Neuroscience, Psychiatry, Uppsala University, Uppsala, Sweden.

Fotios C Papadopoulos (FC)

Department of Neuroscience, Psychiatry, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH